| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.749 | 13.608 | 14.665 | 5.167 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 4.749 | 17.896 | 18.868 | 9.275 | 4.121 | 3.767 | 4.426 |
| Total Expenses - EUR | - | - | 136 | 4.462 | 17.226 | 17.181 | 8.334 | 4.740 | 4.725 | 4.699 |
| Gross Profit/Loss - EUR | - | - | -136 | 287 | 670 | 1.687 | 941 | -618 | -959 | -273 |
| Net Profit/Loss - EUR | - | - | -136 | 239 | 534 | 1.541 | 805 | -618 | -959 | -273 |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Alpha Imunomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 39.406 | 33.717 | 28.246 | 22.895 | 18.226 | 13.445 | 8.671 |
| Current Assets | - | - | 44 | 3.312 | 11.166 | 13.829 | 12.924 | 12.964 | 12.925 | 12.853 |
| Inventories | - | - | 0 | 0 | 248 | 243 | 238 | 239 | 238 | 237 |
| Receivables | - | - | 0 | 516 | 0 | 433 | 423 | 425 | 423 | 421 |
| Cash | - | - | 44 | 2.797 | 10.918 | 13.153 | 12.263 | 12.301 | 12.264 | 12.195 |
| Shareholders Funds | - | - | -92 | 149 | 680 | 2.207 | 2.963 | 2.354 | 1.388 | 1.107 |
| Social Capital | - | - | 44 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | 136 | 3.262 | 9.940 | 10.455 | 8.204 | 8.230 | 8.205 | 8.159 |
| Income in Advance | - | - | 0 | 39.308 | 34.264 | 29.413 | 24.652 | 20.607 | 16.778 | 12.258 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Alpha Imunomed Srl